Condition

Renal Anemia of Chronic Kidney Disease clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Switching dialysis patients on HIF-PHI to long‑acting pegmolesatide for renal anemia

  This study will test whether switching dialysis patients with renal anemia who are taking HIF‑PHI medication to long‑acting pegmolesatide keeps hemoglobin stable and is safe.

  Recruiting Guangdong Provincial People's Hospital · Beijing, Beijing Municipality and 23 other locations · NCT07136792

• Switching to pegmolesatide for anemia in people on dialysis

  This 24-week test will try whether switching dialysis patients whose anemia isn't at goal from rHuEPO to pegmolesatide alone or combined with roxadustat keeps or raises hemoglobin better than continuing rHuEPO.

  Recruiting Phase 4 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07045155

Related topics

Quick answers

How many Renal Anemia of Chronic Kidney Disease clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →